Pharmaceuticals, Biotechnology and Life Sciences
JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a…
Investor Webcast on Tuesday, September 24, 2024 at 8:30 a.m. ETSAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics…
MANKATO, Minn., Sept. 23, 2024 (GLOBE NEWSWIRE) — Digital Utilities Ventures, Inc. (OTC: DUTV), a leader in sustainable energy and…
LEXINGTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ: TTOO) (the “Company”), a leader in the rapid…
WALTHAM, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on…
– New data show istisociclib (KB-0742) triggered cell death in preclinical ovarian cancer models of platinum and PARP-inhibitor (PARPi) resistance –…
Press release OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering Pure-Play CDMO Growth Strategy Continued…
MELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”, or “Genetic Technologies”), a global…
BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) — Cerevance, a company focused on developing precision novel therapeutics for central nervous system…
MELBOURNE, Australia and INDIANAPOLIS, Ind. and LAKE MARY, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX,…